We are live on ! Find out more
DDC

Daniel Devine & Co Portfolio holdings

AUM $125M
1-Year Est. Return 14.12%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$1.99M
Cap. Flow
-$1.63M
Cap. Flow %
-1.31%
Top 10 Hldgs %
65.84%
Holding
52
New
1
Increased
13
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$1.71M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$887K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$402K
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$352K
5
SAP icon
SAP
SAP
+$113K

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$1.33M
2
AZN icon
AstraZeneca
AZN
+$827K
3
HBI
Hanesbrands
HBI
+$821K
4
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$353K
5
ABBV icon
AbbVie
ABBV
+$342K

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.55%
2 Healthcare 11.52%
3 Financials 7.87%
4 Technology 7.08%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$28.6M 22.87%
105,457
+1,490
+1% +$402K
QQQ icon
2
Invesco QQQ Trust
QQQ
$474B
$15.1M 12.07%
87,980
– –
MDY icon
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
$13.1M 10.47%
36,890
+1,000
+3% +$352K
AAPL icon
4
Apple
AAPL
$4.84T
$7.54M 6.03%
163,032
– –
IBB icon
5
iShares Biotechnology ETF
IBB
$10.3B
$3.92M 3.13%
35,655
– –
JNJ icon
6
Johnson & Johnson
JNJ
$644B
$3.59M 2.87%
29,607
-850
-3% -$106K
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.11T
$2.93M 2.34%
15,700
– –
V icon
8
Visa
V
$701B
$2.66M 2.13%
20,080
– –
ABBV icon
9
AbbVie
ABBV
$465B
$2.49M 1.99%
26,880
-3,500
-12% -$342K
CVX icon
10
Chevron
CVX
$427B
$2.43M 1.94%
19,214
-2,000
-9% -$248K
EEM icon
11
iShares MSCI Emerging Markets ETF
EEM
$30.6B
$2.41M 1.93%
55,625
– –
UNH icon
12
UnitedHealth
UNH
$337B
$2.2M 1.76%
8,965
– –
HON icon
13
Honeywell
HON
$64.5B
$2.07M 1.65%
15,891
-1,218
-7% -$162K
PFE icon
14
Pfizer
PFE
$157B
$1.98M 1.58%
57,400
-5,059
-8% -$173K
COST icon
15
Costco
COST
$400B
$1.96M 1.56%
9,365
– –
FDX icon
16
FedEx
FDX
$73B
$1.93M 1.54%
8,510
– –
ZTS icon
17
Zoetis
ZTS
$30.3B
$1.91M 1.53%
22,440
+150
+0.7% +$12.7K
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.22T
$1.9M 1.52%
33,680
-300
-0.9% -$16.3K
WMT icon
19
Walmart Inc
WMT
$858B
$1.72M 1.37%
+60,075
New +$1.71M
BLK icon
20
Blackrock
BLK
$164B
$1.7M 1.36%
3,410
+50
+1% +$26.4K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.18T
$1.7M 1.36%
30,420
+720
+2% +$38.9K
DIS icon
22
Walt Disney
DIS
$184B
$1.55M 1.24%
14,762
+510
+4% +$52.2K
NVS icon
23
Novartis
NVS
$263B
$1.39M 1.11%
20,590
-3,571
-15% -$246K
SBUX icon
24
Starbucks
SBUX
$110B
$1.34M 1.07%
27,425
-2,150
-7% -$122K
SAP icon
25
SAP
SAP
$249B
$1.32M 1.05%
11,375
+1,000
+10% +$113K
1
2

Similar funds

PMLI
Penn Mutual Life Insurance Horsham, Pennsylvania $125M AUM 9.1% 1-Year Est. Return
KFA
Kabarec Financial Advisors Palatine, Illinois $131M AUM
FAM
Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return
MFP
Mosaic Financial Partners San Francisco, California $152M AUM 1.45% 1-Year Est. Return
MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
MAI
Marble Arch Investments New York $82.3M AUM 31.35% 1-Year Est. Return
XGI
XL Group Investments Hamilton, Bermuda $169M AUM 13.59% 1-Year Est. Return
ACM
Altalis Capital Management New York $79.7M AUM 1.72% 1-Year Est. Return

Daniel Devine & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Daniel Devine & Co held 52 positions worth $125M, up 1.6% from $123M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Daniel Devine & Co's Q2 2018 filing shows 1 new, 13 increased, 13 reduced and 4 closed positions. Its largest new stake was Walmart Inc: 60,075 shares worth $1.72M. The largest sale was Target, an estimated $1.33M.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 54% a quarter earlier, followed by Healthcare and Financials.

  • Daniel Devine & Co's largest Q2 2018 buy was Walmart Inc: 60,075 shares worth $1.72M.
  • Daniel Devine & Co added most to Vanguard S&P 500 ETF in Q2 2018, an estimated $887K increase.
  • Daniel Devine & Co's biggest Q2 2018 reduction was AstraZeneca, cutting an estimated $827K.
  • Daniel Devine & Co fully exited Target in Q2 2018, selling an estimated $1.33M.
  • Daniel Devine & Co's ten largest holdings make up 66% of its $125M portfolio in Q2 2018.
  • Daniel Devine & Co opened 1 new position and closed 4 in Q2 2018.
  • Daniel Devine & Co's portfolio value rose 1.6% quarter-over-quarter to $125M.

Based on Daniel Devine & Co's 13F filing for Q2 2018, filed 18 Jul 2018.